<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33269497</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>27</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-3468</ISSN><JournalIssue CitedMedium="Internet"><Volume>595</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Feb</Month></PubDate></JournalIssue><Title>FEBS letters</Title><ISOAbbreviation>FEBS Lett</ISOAbbreviation></Journal><ArticleTitle>Different recognition modes of G-quadruplex RNA between two ALS/FTLD-linked proteins TDP-43 and FUS.</ArticleTitle><Pagination><StartPage>310</StartPage><EndPage>323</EndPage><MedlinePgn>310-323</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/1873-3468.14013</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis/frontotemporal lobar degeneration-linked proteins, TDP-43 and fused in sarcoma (FUS), bind to G-quadruplex-containing mRNAs and transport them to distal neurites for local translation. The specificity and mechanism of G4-RNA binding, however, remain largely unsolved. Using purified full-length TDP-43 and FUS and a set of seven G4-DNA/RNA, we compared their recognition properties of G4-RNAs. Both TDP-43 and FUS recognized and bound to G4-DNA/RNAs, but the target selectivity differed between two proteins. TDP-43 recognized only parallel-stranded G4-DNA/RNAs, leading to stabilize the G4 conformation. In contrast, FUS bound to all three types, parallel, hybrid, and antiparallel, of G4-DNA/RNAs, resulting in deformation of the G4 structure. We then concluded that the target selectivity and the influence on G4 RNA structure differed between TDP-43 and FUS.</AbstractText><CopyrightInformation>&#xa9; 2020 Federation of European Biochemical Societies.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ishiguro</LastName><ForeName>Akira</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1867-3134</Identifier><AffiliationInfo><Affiliation>Research Center for Micro-Nano Technology, Hosei University, Koganei, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katayama</LastName><ForeName>Akira</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0050-1126</Identifier><AffiliationInfo><Affiliation>Department of Molecular Analysis Laboratory, Nippon Medical School, Bunkyo-ku, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishihama</LastName><ForeName>Akira</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6339-9042</Identifier><AffiliationInfo><Affiliation>Research Center for Micro-Nano Technology, Hosei University, Koganei, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>12</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>FEBS Lett</MedlineTA><NlmUniqueID>0155157</NlmUniqueID><ISSNLinking>0014-5793</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003001" MajorTopicYN="N">Cloning, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057174" MajorTopicYN="N">Frontotemporal Lobar Degeneration</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054856" MajorTopicYN="Y">G-Quadruplexes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005822" MajorTopicYN="N">Genetic Vectors</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009690" MajorTopicYN="N">Nucleic Acid Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054730" MajorTopicYN="N">Protein Interaction Domains and Motifs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">FUS</Keyword><Keyword MajorTopicYN="N">G-quadruplex (G4)</Keyword><Keyword MajorTopicYN="N">RNA</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">frontotemporal lobar degeneration</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>3</Day><Hour>5</Hour><Minute>48</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33269497</ArticleId><ArticleId IdType="doi">10.1002/1873-3468.14013</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Kim J, Cheong C and Moore PB (1991) Tetramerization of an RNA oligonucleotide containing GGGG sequence. Nature 23, 331-332.</Citation></Reference><Reference><Citation>Sen D and Gilbert W (1988) Formation of parallel four-stranded complexes by guanine-rich motifs in DNA and its implications for meiosis. Nature 334, 364-366.</Citation></Reference><Reference><Citation>Lane AN, Chaires JB, Gray RD and Trent JO (2008) Stability and kinetics of G-quadruplex structures. Nucleic Acids Res 36, 5482-5515.</Citation></Reference><Reference><Citation>Burge S, Parkinson GN, Hazel P, Todd AK and Neidle S (2006) Quadruplex DNA: sequence, topology and structure. Nucleic Acids Res 34, 5402-5415.</Citation></Reference><Reference><Citation>Shafer RH and Smirnov I (2001) Biological aspects of DNA/RNA quadruplexes. Biopolymers 56, 209-227.</Citation></Reference><Reference><Citation>Sarahathan N and Vivekanandan P (2019) G-quadruplexes: more than just a kink in microbial genomes. Trends Microbiol 27, 148-163.</Citation></Reference><Reference><Citation>Fay MM, Lyons SM and Ivanov P (2017) RNA G-quadruplexes in biology: principles and molecular mechanisms. J Mol Biol 429, 2127-2147.</Citation></Reference><Reference><Citation>Rhodes D and Lipps HJ (2015) G-quadruplexes and their regulatory roles in biology. Nucleic Acids Res 43, 8627-8637.</Citation></Reference><Reference><Citation>Brazda V, Haronikova L, Liao JCC and Fojta M (2014) DNA and RNA quadruplex-binding proteins. Int J Med Sci 15, 17493-17517.</Citation></Reference><Reference><Citation>Sissi C, Gatto B and Palumbo M (2011) The evolving world of protein-G-quadruplex recognition: a medicinal chemist&#x2019;s perspective. Biochimie 93, 1219-1230.</Citation></Reference><Reference><Citation>Lunde BM, Moore C and Varani G (2007) RNA-binding proteins: molecular design for efficient function. Nat Rev Mol Cell Biol 8, 479-490.</Citation></Reference><Reference><Citation>Kharel P, Balaratnam S, Beals N and Basu S (2020) The role of RNA G-quadruplexes in human diseases and therapeutic strategies. WIREs RNA 11, e1568.</Citation></Reference><Reference><Citation>Asamitsu S, Takeuchi M, Ikenoshita S, Imai Y, Kashiwagi H and Shioda N (2019) Perspectives for applying G-quadruplex structures in neurobiology and neuropharmacology. Int J Mol Sci 20, 2884.</Citation></Reference><Reference><Citation>Maizels N (2015) G4-associated human diseases. EMBO Rep 16, 910-922.</Citation></Reference><Reference><Citation>Ishiguro A, Kimura N, Noma T, Shimo-Kon R, Ishihama A and Kon T (2020) Molecular dissection of ALS-linked TDP-43: involvement of the Gly-rich domain in interaction with G-quadruplex mRNA. FEBS Lett 594, 2254-2265.</Citation></Reference><Reference><Citation>Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y et al. (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351, 602-611.</Citation></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM et al. (2006) Uniquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130-133.</Citation></Reference><Reference><Citation>Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, Davis A, Gilchrist J, Kasarskis EJ, Munsat T et al. (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323, 1205-1209.</Citation></Reference><Reference><Citation>Vance C, Rogelj B, Hortob&#xe1;gyi T, De Vos KJ, Nishimura AL, Sreedharan J, Hu X, Smith B, Ruddy D, Wright P et al. (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323, 1208-1210.</Citation></Reference><Reference><Citation>Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, Ackerley S, Durnall JC, Williams KL, Buratti E et al. (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319, 1668-1671.</Citation></Reference><Reference><Citation>Ederle H and Dormann D (2017) TDP-43 and FUS en route from the nucleus to the cytoplasm. FEBS Lett 591, 1489-1507.</Citation></Reference><Reference><Citation>Guerrero EN, Wang H, Mitra J, Hegde PM, Stowell SE, Liachko NF, Kraemer BC, Garruto RM, Rao KS and Hegde ML (2016) TDP-43/FUS in motor neuron disease: complexity and challenges. Prog Neurogibol 145-146, 78-97.</Citation></Reference><Reference><Citation>Ratti A and Buratti E (2016) Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins. J Neurochem 138, 95-111.</Citation></Reference><Reference><Citation>Da Cruz S and Cleveland DW (2011) Understanding the role of TDP-43 and FUS/TLS in ALS and beyond. Curr Opin Neurobiol 21, 904-919.</Citation></Reference><Reference><Citation>Strong HJ and Volkening K (2011) TDP-43 and FUS/TLS: sending a complex message about messenger RNA in amyotrophic lateral sclerosis? FEBS J 278, 3569-3577.</Citation></Reference><Reference><Citation>Lagier-Tourenne C, Polymenidou M and Cleveland DW. (2010) TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Human Mol Genet 19, R46-R64.</Citation></Reference><Reference><Citation>Von Hacht A, Seifert O, Menger M, Scyutze T, Arora A, Konthur Z, Neubauer P, Wagner A, Weise C and Kurreck J (2014) Identification and characterization of RNA quinine-quadruplex binding proteins. Nucleic Acids Res 42, 6630-6644.</Citation></Reference><Reference><Citation>Ishiguro A, Kimura N, Watanabe Y, Watanabe S and Ishihama A (2016) TDP-43 binds and transports G-quadruplex-containing mRNAs into neurites for local translation. Genes Cells 21, 466-481.</Citation></Reference><Reference><Citation>Lukavsky PJ, Daujotyte D, Tollervey JR, Ule J, Stuani C, Buratti E, Baralle FE, Damberger FF and Allain FH (2013) Molecular basis of UG-rich RNA recognition by the human splicing factor TDP-43. Nat Struct Mol Biol 20, 1443-1449.</Citation></Reference><Reference><Citation>Buratti E, Dork T, Zuccato E, Pagani F, Romano M and Baralle FE (2001) Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J 20, 1774-1784.</Citation></Reference><Reference><Citation>Imperatore JA, McAninch DS, Valdez-Sinon AN, Bassell GJ and Mihailescu MR (2020) FUS recognizes G quadruplex structures within neuronal mRNAs. Front Mol Biosci 7, 6.</Citation></Reference><Reference><Citation>Takahama K, Takada A, Toda S, Shimizu M, Sayama K, Kurokawa R and Oyoshi T (2013) Regulation of telomere length by G-quadruplex telomere DNA- and TERRA-binding protein TLS/FUS. Chemist Biol 20, 341-350.</Citation></Reference><Reference><Citation>Zamiri B, Reddy K, Macgregor RB Jr and Pearson CE (2014) TMPyP4 porphyrin distorts RNA G-quadruplex structures of the disease-associated r(GGGGCC)n repeat of the C9orf72 gene and blocks interaction of RNA-binding proteins. J Biol Chem 289, 4653-4659.</Citation></Reference><Reference><Citation>Ozoline ON, Fujita N and Ishihama A (2001) Mode of DNA-protein interaction between the C-terminal domain of Escherichia coli RNA polymerase a subunit and T7D promoter UP element. Nucleic Acids Res 29, 4909-4919.</Citation></Reference><Reference><Citation>Loughlin FE, Lukavsky PJ, Kazeeva T, Reber S, Hock EM, Colombo M, Von Schroetter C, Pauli P, Cl&#xe9;ry A, M&#xfc;hlemann O et al. (2019) The solution structure of FUS bound to RNA reveals a bipartite mode of RNA recognition with both sequence and shape specificity. Mol Cell 73, 490-504.</Citation></Reference><Reference><Citation>Mohanty J, Barooah N, Dhamodharan V, Harikrishna S, Pradeepkumar PI and Bhasikuttan AC (2013) Thioflavin T as an efficient inducer and selective fluorescent sensor for the human telomeric G-quadruplex DNA. J Amer Chem Soc 135, 367-376.</Citation></Reference><Reference><Citation>Greiner DP, Miyake R, Moran JK, Jones AD, Negishi T, Ishihama A and Meares CF (1997) Synthesis of the protein cutting reagent iron(S)-1-(p-bromoacetamidobenzyl)ethylenediaminetetraacetate and conjugation to cysteine side chains. Bioconjug Chem 8, 44-48.</Citation></Reference><Reference><Citation>Liu X and Xu Y (2018) HnRNPA1 specifically recognizes the base of nucleotide at the loop of RNA G-quadruplex. Molecules 23, 237.</Citation></Reference><Reference><Citation>Scalabrin M, Frasson I, Ruggiero E, Perrone R, Tosoni E, Lago S, Tassinari M, Palu G and Richter SN (2017) The cellular protein hnRNP A2/B1 enhances HIV-1 transcription by unfolding LTR promoter G-quadruplexes. Sci Rep 7, 45244.</Citation></Reference><Reference><Citation>Mori K, Lammich S, Mackenzie IR, Forn&#xe9; I, Zilow S, Kretzschmar H, Edbauer D, Janssens J, Kleinberger G, Cruts M et al. (2013) hnRNP A3 binds to GGGGCC repeats and is a constituent of p62-positive/TDP43-negative inclusions in the hippocampus of patients with C9orf92 mutations. Acta Neuropathol 125, 413-423.</Citation></Reference><Reference><Citation>Oyoshi T and Kurokawa R (2012) Structure of noncoding RNA is a determinant of function of RNA binding proteins in transcription regulation. Cell Biosci 2, 1.</Citation></Reference><Reference><Citation>Takahama K, Kino K, Arai S, Kurokawa R and Oyoshi T (2011) Identification of Ewing&#x2019;s sarcoma protein as a G-quadruplex DNA- and RNA-binding protein. FEBS J 278, 988-998.</Citation></Reference><Reference><Citation>Bentmann E, Haass C and Dormann D (2013) Stress granules in neurodegeneration - lessons learnt from TAR DNA binding protein of 43 kDa and fused in sarcoma. FEBS J 280, 4348-4437.</Citation></Reference><Reference><Citation>Reddy K, Zamiri B, Stanley SY, Macgregor RB Jr and Pearson CE (2013) The disease-associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length-dependent uni- and multimolecular RNA G-quadruplex structures. J Biol Chem 288, 9860-9866.</Citation></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J et al. (2011) Expended GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72, 245-256.</Citation></Reference><Reference><Citation>Krokidis MG and Vlamos P (2018) Transcriptomics in amyotrophic lateral sclerosis. Front Biosci 10, 103-121.</Citation></Reference><Reference><Citation>van Rheenen W, Diekstra FP, Harschnitz O, Westeneng HJ, van Eijk KR, Saris CGJ, Groen EJN, van Es MA, Blauw HM, van Vught PWJ et al. (2018) Whole blood transcriptome analysis in amyotrophic lateral sclerosis: a biomarker study. PLoS One 13, e0198874.</Citation></Reference><Reference><Citation>Dominguez D, Freese P, Alexis MS, Su A, Hochman M, Palden T, Bazile C, Lambert NJ, Van Nostrand EL, Pratt GA et al. (2018) Sequence, structure, and context preferences of human RNA binding proteins. Mol Cell 70, 854-867.</Citation></Reference><Reference><Citation>Jankowsky E and Harris M (2015) Specificity and nonspecificity in RNA-protein interactions. Nat Rev Mol Cell Biol 16, 533-544.</Citation></Reference><Reference><Citation>Auweter SD, Oberstrass FC and Allain FH-T (2006) Sequence-specific binding of single-stranded RNA: is there a code for recognition? Nucleic Acids Res 34, 4943-4959.</Citation></Reference><Reference><Citation>Balcerak A, Trebinska-Stryjewska A, Konopinski R, Wakula M and Grzybowska EA (2019) RNA-protein interactions: disorder, moonlighting and junk contribute to eukaryotic complexity. Open Biol 9, 190096.</Citation></Reference><Reference><Citation>Dormann D and Haass C (2011) TDP-43 and FUS: a nuclear affair. Trends Nerurosci 34, 339-348.</Citation></Reference><Reference><Citation>Ishikawa K and Nagai Y (2019) Molecular mechanisms and future therapeutics for spinocerebellar ataxia type 31 (SCA31). Neurotherapeutics 16, 1106-1114.</Citation></Reference><Reference><Citation>Subramanian M, Rage F, Tabet R, Flatter E, Mandel JL and Moine H (2011) G-quadruplex RNA structure as a signal for neurite mRNA targeting. EMBO Rep 12, 697-704.</Citation></Reference><Reference><Citation>Collie GW, Haider SM, Neidle S and Parkinson GN (2010) A crystallographic and modelling study of a human telomeric RNA (TERRA) quadruplex. Nucleic Acids Res 38, 5569-5580.</Citation></Reference><Reference><Citation>Grigg JC, Shumayrikh N and Sen D (2014) G-guadruplex structures formed by expanded hexanucleotide repeat RNA and DNA from the neurodegenerative disease-linked C9orf72 gene efficiently sequester and activate heme. PLoS One 9, e10 1371.</Citation></Reference><Reference><Citation>Haeusler AR, Donnelly CJ, Periz G, Simko EA, Shaw PG, Kim MS, Maragakis NJ, Troncoso JC, Pandey A, Sattler R et al. (2014) C9orf72 nucleotide repeat structures initiate molecular cascades of diseases. Nature 507, 195-200.</Citation></Reference><Reference><Citation>Zhang X-Y, Cao E-H, Zhang Y and Bai C (2003) K+ and Na+-induced self-assembly of telomeric oligonucleotide d)TTAGGG)n. J Biomol Struct Dyn 20, 693-702.</Citation></Reference><Reference><Citation>Ambrus A, Chen D, Dai J, Bialis T, Jones RA and Yang D (2006) Human telomeric sequence forms a hybrid-type intramolecular G-quadruplex structure with mixed parallel/antiparallel strands in potassium solution. Nucleic Acids Res 34, 2723-2735.</Citation></Reference><Reference><Citation>Kr&#xfc;ger AC, Raarup MK, Nielsen MM, Kristensen M, Besenbacher F, Kjems J and Birkedal V (2010) Interaction of hnRNP A1 with telomere DNA G-quadruplex structures studied at the single molecule level. Europ Biophysic J 39, 1343-1350.</Citation></Reference><Reference><Citation>Simonsson T and Sj&#xf6;back R (1999) DNA tetraplex formation studied with fluorescence resonance energy transfer. J Biol Chem 274, 17379-17383.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>